Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q3
ALKERMES, INC. for ALKERMES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse, Tariff (miscellaneous tariff bills)
View → Q3
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View → Q3
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View → Q3
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $70,000.00 income
Medicare/Medicaid
View → Q3
LMH STRATEGIC SOLUTIONS for ALKERMES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $90,000.00 income
Medicare/Medicaid
View → Q3
TIBER CREEK GROUP for INCYTE CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View → Q3
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q3
TIBER CREEK GROUP for EMD SERONO, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View → Q3
TIBER CREEK GROUP for ASTRAZENECA
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View → Q3
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View → Q3
JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Pharmacy
View → Q3
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q3
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View → Q3
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues
View → Q3
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Trade (domestic/foreign)
View → Q3
THE NICKLES GROUP, LLC for MERCK & CO. INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q3
THE NICKLES GROUP, LLC for UCB, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Georgia · House · Senate · $60,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View → Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q3
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → 2T
TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View → Q3
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View → 2A
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View → 2A
PFIZER INC. for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q2
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Previous Page 6 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem